COVID-19 vaccine: Moderna to seek emergency use authorisation from US, European regulators
Moderna said the primary efficacy analysis of the Phase-3 study of its vaccine candidate indicates a vaccine efficacy of 94.1%.
Full Article
COVID-19 vaccine: Moderna to seek emergency use authorisation from US, European regulators
DNA
0 shares
1 views
You might like
Related news coverage
Covid-19 coronavirus: Moderna asking US, European regulators to approve its doses
New Zealand Herald
Moderna Inc. said it would ask United States and European regulators to allow emergency use of its Covid-19 vaccine as new study..
-
Nikola, JetBlue fall; Moderna, Novavax rise
SeattlePI.com
-
US stocks end down to close a historic November rally
Proactive Investors
-
VIRUS TODAY: Vaccine gains momentum, NFL season in chaos
SeattlePI.com
-
US stocks seeing red at mid-session; Dow Jones looks for best monthly gain since 1987
Proactive Investors
Advertisement
More coverage
Moderna vaccine 100 per cent effective against severe COVID-19
Mid-Day
US biotech company Moderna on Monday announced that it plans to request an Emergency Use Authorization (EUA) from the US Food and..
-
Moderna asks US, European regulators, to allow emergency use of COVID-19 vaccine
Zee News
-
Moderna Asking FDA, European Regulators To Approve Its COVID Vaccine After Trial ‘Already Saved Lives’
CBS 2
-
Moderna asking US, European regulators to OK its virus shots
Upworthy
-
Stock Alert: Moderna Jumps 16% As Covid Vaccine 94.1% Effective; To Apply For Emergency Use
RTTNews